TY - JOUR
T1 - Vascular responses in vivo to 8-epi PGF2α in normal and hypercholesterolemic pigs
AU - Krier, James D.
AU - Rodriguez-Porcel, Martin
AU - Best, Patricia J.M.
AU - Carlos Romero, J.
AU - Lerman, Amir
AU - Lerman, Lilach O.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Hypercholesterolemia (HC) is characterized by increased circulating 8-epi-prostaglandin-F2α (isoprostane), a vasoconstrictor, marker, and mediator of increased oxidative stress, whose vascular effects might be augmented in HC. Anesthetized pigs were studied in vivo with electron beam computed tomography after a 12-wk normal (n = 8) or HC (n = 8) diet. Mean arterial pressure (MAP), single-kidney perfusion, and glomerular filtration rate (GFR) were quantified before and during unilateral intrarenal infusions of U46619 (10 ng·kg-1·min-1 or isoprostane (1 μg·kg-1·min-1). Basal renal perfusion and function were similar, and isoprostane infusion elevated its systemic levels similarly in normal and HC (333 ± 89 vs. 366 ± 48 pg/ml, respectively, P < 0.01 vs. baseline). Both drugs markedly and comparably decreased cortical perfusion and GFR in both groups, whereas medullary perfusion decreased significantly only in HC. Moreover, MAP increased significantly only in HC (+9 ± 3 and +11 ± 3 mmHg, respectively, P≤ 0.05). Hence, in HC, renal functional responses to high-dose isoprostane are largely similar to normal, but the systemic circulation exhibits augmented sensitivity to pathophysiological levels of isoprostane and U46619, which may potentially play a role in development of hypertension and vascular injury associated with increased oxidative stress.
AB - Hypercholesterolemia (HC) is characterized by increased circulating 8-epi-prostaglandin-F2α (isoprostane), a vasoconstrictor, marker, and mediator of increased oxidative stress, whose vascular effects might be augmented in HC. Anesthetized pigs were studied in vivo with electron beam computed tomography after a 12-wk normal (n = 8) or HC (n = 8) diet. Mean arterial pressure (MAP), single-kidney perfusion, and glomerular filtration rate (GFR) were quantified before and during unilateral intrarenal infusions of U46619 (10 ng·kg-1·min-1 or isoprostane (1 μg·kg-1·min-1). Basal renal perfusion and function were similar, and isoprostane infusion elevated its systemic levels similarly in normal and HC (333 ± 89 vs. 366 ± 48 pg/ml, respectively, P < 0.01 vs. baseline). Both drugs markedly and comparably decreased cortical perfusion and GFR in both groups, whereas medullary perfusion decreased significantly only in HC. Moreover, MAP increased significantly only in HC (+9 ± 3 and +11 ± 3 mmHg, respectively, P≤ 0.05). Hence, in HC, renal functional responses to high-dose isoprostane are largely similar to normal, but the systemic circulation exhibits augmented sensitivity to pathophysiological levels of isoprostane and U46619, which may potentially play a role in development of hypertension and vascular injury associated with increased oxidative stress.
KW - Glomerular filtration rate
KW - Hypercholesterolemia
UR - http://www.scopus.com/inward/record.url?scp=0036333665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036333665&partnerID=8YFLogxK
U2 - 10.1152/ajpregu.00602.2001
DO - 10.1152/ajpregu.00602.2001
M3 - Article
C2 - 12121841
AN - SCOPUS:0036333665
SN - 0363-6119
VL - 283
SP - R303-R308
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 2 52-2
ER -